6.
Liu Y, Sherer B, Redetzke R, Gerdes A
. Regulation of arteriolar density in adult myocardium during low thyroid conditions. Vascul Pharmacol. 2009; 52(3-4):146-50.
DOI: 10.1016/j.vph.2009.10.003.
View
7.
Crespo-Leiro M, Anker S, Maggioni A, Coats A, Filippatos G, Ruschitzka F
. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016; 18(6):613-25.
DOI: 10.1002/ejhf.566.
View
8.
Medic F, Bakula M, Alfirevic M, Bakula M, Mucic K, Maric N
. AMIODARONE AND THYROID DYSFUNCTION. Acta Clin Croat. 2023; 61(2):327-341.
PMC: 9934045.
DOI: 10.20471/acc.2022.61.02.20.
View
9.
De Leo S, Lee S, Braverman L
. Hyperthyroidism. Lancet. 2016; 388(10047):906-918.
PMC: 5014602.
DOI: 10.1016/S0140-6736(16)00278-6.
View
10.
Taylor P, Iqbal A, Minassian C, Sayers A, Draman M, Greenwood R
. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 2013; 174(1):32-9.
DOI: 10.1001/jamainternmed.2013.11312.
View
11.
Narayana S, Woods D, Boos C
. Management of amiodarone-related thyroid problems. Ther Adv Endocrinol Metab. 2012; 2(3):115-26.
PMC: 3474631.
DOI: 10.1177/2042018811398516.
View
12.
Bozkurt B, Coats A, Tsutsui H, Abdelhamid C, Adamopoulos S, Albert N
. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal.... Eur J Heart Fail. 2021; 23(3):352-380.
DOI: 10.1002/ejhf.2115.
View
13.
Cardenas G, Cabral J, Leslie C
. Amiodarone induced thyrotoxicosis: diagnostic and therapeutic strategies. Cleve Clin J Med. 2003; 70(7):624-6, 628-31.
DOI: 10.3949/ccjm.70.7.624.
View
14.
Biondi B, Palmieri E, Lombardi G, Fazio S
. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002; 137(11):904-14.
DOI: 10.7326/0003-4819-137-11-200212030-00011.
View
15.
Triggiani V, Giagulli V, De Pergola G, Licchelli B, Guastamacchia E, Iacoviello M
. Mechanisms Explaining the Influence of Subclinical Hypothyroidism on the Onset and Progression of Chronic Heart Failure. Endocr Metab Immune Disord Drug Targets. 2015; 16(1):2-7.
DOI: 10.2174/1871530316666151218151319.
View
16.
Harada K, Murakami S, Tokumasu K, Togawa Y, Otsuka F
. Myxedema coma accompanied by sick sinus syndrome and hypoventilation: A case report. J Gen Fam Med. 2019; 20(5):206-208.
PMC: 6732564.
DOI: 10.1002/jgf2.267.
View
17.
Raeder E, Podrid P, LOWN B
. Side effects and complications of amiodarone therapy. Am Heart J. 1985; 109(5 Pt 1):975-83.
DOI: 10.1016/0002-8703(85)90238-8.
View
18.
Triggiani V, Iacoviello M
. Thyroid disorders in chronic heart failure: from prognostic set-up to therapeutic management. Endocr Metab Immune Disord Drug Targets. 2013; 13(1):22-37.
DOI: 10.2174/1871530311313010005.
View
19.
Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A
. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special.... Eur Heart J. 2016; 37(27):2129-2200.
DOI: 10.1093/eurheartj/ehw128.
View
20.
Mujovic N, Dobrev D, Marinkovic M, Russo V, Potpara T
. The role of amiodarone in contemporary management of complex cardiac arrhythmias. Pharmacol Res. 2019; 151:104521.
DOI: 10.1016/j.phrs.2019.104521.
View